Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations - Wikidata - wikimedia - TriplyDB

Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations

Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations

http://www.wikidata.org/entity/Q28397752

about

Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis Integration of published information into a resistance-associated mutation database for Mycobacterium tuberculosis Performance Comparison of Three Rapid Tests for the Diagnosis of Drug-Resistant Tuberculosis The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review Comparative Evaluation of Sloppy Molecular Beacon and Dual-Labeled Probe Melting Temperature Assays to Identify Mutations in Mycobacterium tuberculosis Resulting in Rifampin, Fluoroquinolone and Aminoglycoside Resistance Detection of Low-Level Mixed-Population Drug Resistance in Mycobacterium tuberculosis Using High Fidelity Amplicon Sequencing Integrated microfluidic card with TaqMan probes and high-resolution melt analysis to detect tuberculosis drug resistance mutations across 10 genes.Microbial genomics and antimicrobial susceptibility testing.Accurate and effective multidrug-resistant Mycobacterium tuberculosis detection method using gap-filling ligation coupled with high-resolution capillary electrophoresis-based single strand conformation polymorphism.Draft Genome Sequence of the First Isolate of Extensively Drug-Resistant Mycobacterium tuberculosis in New Zealand.KvarQ: targeted and direct variant calling from fastq reads of bacterial genomes.Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countries Disparities in capreomycin resistance levels associated with the rrs A1401G mutation in clinical isolates of Mycobacterium tuberculosis.Prevalence of Tuberculosis, Drug Susceptibility Testing, and Genotyping of Mycobacterial Isolates from Pulmonary Tuberculosis Patients in Dessie, Ethiopia The potential of a multiplex high-throughput molecular assay for early detection of first and second line tuberculosis drug resistance mutations to improve infection control and reduce costs: a decision analytical modeling study.Phenotypic and genotypic diversity in a multinational sample of drug-resistant Mycobacterium tuberculosis isolates.Primary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates.Predicting differential rifamycin resistance in clinical Mycobacterium tuberculosis isolates by specific rpoB mutations.Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape Rapid Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates Directly from Clinical Samples by Use of Amplicon Sequencing: a Proof-of-Concept Study.Comparative Study of Eis-like Enzymes from Pathogenic and Nonpathogenic Bacteria.Detection of Isoniazid-, Fluoroquinolone-, Amikacin-, and Kanamycin-Resistant Tuberculosis in an Automated, Multiplexed 10-Color Assay Suitable for Point-of-Care Use.Impact of gyrB and eis Mutations in Improving Detection of Second-Line-Drug Resistance among Mycobacterium tuberculosis Isolates from Georgia.Genetic Determinants of Drug Resistance in Mycobacterium tuberculosis and Their Diagnostic Value RAIRS2 a new expert system for diagnosing tuberculosis with real-world tournament selection mechanism inside artificial immune recognition system.Draft Genome Sequence of a Drug-Susceptible New Zealand Isolate of Mycobacterium tuberculosis Lineage 3.Draft Genome Sequence of the First Isolate of Extensively Drug-Resistant Mycobacterium tuberculosis in Ireland.Draft Genome Sequence of a Multidrug-Resistant New Zealand Isolate of Mycobacterium tuberculosis Lineage 3.Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting.Cryptic Microheteroresistance Explains Mycobacterium tuberculosis Phenotypic Resistance.Peroxidase improves the activity of catalase by preventing aggregation during TFE-induced denaturation.Draft Genome Sequence of the First Confirmed Isolate of Multidrug-Resistant Mycobacterium tuberculosis in Tasmania.Genotyping Multi-Drug Resistant M. tuberculosis from Primary Sputum and Decontaminated Sediment with an Integrated Microfluidic Amplification Microarray.Molecular epidemiology of tuberculosis in Tasmania and genomic characterisation of its first known multi-drug resistant case.PCR free multiple ligase reactions and probe cleavages for the SNP detection of KRAS mutation with attomole sensitivity.A rapid culture system uninfluenced by an inoculum effect increases reliability and convenience for drug susceptibility testing of Mycobacterium tuberculosis.

P2860

Q27004697-28ED0B0D-E803-4836-B1A5-437F4767A8E8 Q27342229-F9867EC1-1D7A-4B5A-B04A-61A349991744 Q28087770-EA82CA9A-8ED9-495A-BBA4-73886340824A Q28387375-51B6AA78-4C21-4E2E-9B92-FCE40857A249 Q28397729-B6511249-7887-44B6-9FCA-03277B8C7CA4 Q28544877-5FA27F90-927A-42E6-AF9E-E15D1C8A29EC Q28545095-29229C02-D3C5-4752-93A0-6C78C787F3F2 Q28546999-4B327262-7ED9-4AC6-B14D-7F4734868CC0 Q28547220-02FB4B1B-8D49-4902-B36E-97F146B82847 Q30300560-C01FD413-66D4-4708-8E3B-A7142EDCB0F4 Q30397574-E42ED5FC-076B-4908-A5AE-235DF59B929C Q33576611-6DF69178-D82C-4C56-A380-6ED4FAA18137 Q33584660-4FD0FE6F-8041-44A2-BCF8-6318B116E589 Q34340287-52F3F184-5C4F-4210-9A30-73AE7F7CEC00 Q34922635-974D8F8A-6703-49CD-8595-58587F868A85 Q34922710-09861670-B216-4E9B-BF3C-1FB9DD6FE547 Q35769140-8E6BCD5A-D54A-44E6-AAAA-F5A1BDF4C62B Q35822104-EA692A78-F197-477A-BE7F-3D5B8FE3A8BF Q35828310-A4537118-9B17-4226-88D1-D95EAE305660 Q35850402-A5E5035A-4C6A-413A-A920-02D3D65262B2 Q35909558-DEBD66C0-CF4C-4887-A5B7-AA57426C5178 Q36169719-0DEE8880-C30B-4D3F-8AE4-A83DBA9290D8 Q37023127-8D3E203E-2168-4C59-A6F6-AFDEFDFCACB4 Q37132034-7B6E1223-18A5-4F8A-B8DC-441D0C91CF6D Q37499353-57715841-EEC5-475F-A2B4-70F0A8AB957D Q37581864-D8B00331-C8C4-4A18-A323-5A9D536EF7E3 Q38718388-91C5FEBD-A8F2-4A08-9957-42701E191031 Q38999525-4A1D5AE5-38BB-44EE-B721-9ADC79873591 Q40829224-9014FFA9-140C-4DCC-A199-2F0AA9D2CCC5 Q40957415-DE3F322C-7516-43E8-BE9D-D52F71B0D2B5 Q41765905-D459B983-B702-47CE-B68E-26B43A84159D Q41895871-F035DFB1-D5F9-43C4-A654-A96BA9DD30CE Q42708370-D17A5DA1-11AD-455B-822E-154C687F776E Q46589487-72D4F46E-F6CD-46B5-9E3D-E4B722A49539 Q46737258-14BE59A4-0D53-4440-847A-A7FAE70D0028 Q47109976-9835EE17-29A9-4185-8394-346255D53C0E Q47203483-E24C459B-F0C0-4980-9876-4D004EA3913C Q50351099-7693649C-71CD-42BC-AB66-39B11EA34B4B Q51107893-E45FBF00-9F7A-4285-A375-7817BBDD8395 Q55227253-796F14CC-C3DF-4C88-8A60-9E27A1AAC795

P2860

Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations

http://www.wikidata.org/entity/Q28397752

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Predicting extensively drug-re ...... notypes with genetic mutations

@ast

Predicting extensively drug-re ...... notypes with genetic mutations

@en

Predicting extensively drug-re ...... notypes with genetic mutations

@nl

type

label

Predicting extensively drug-re ...... notypes with genetic mutations

@ast

Predicting extensively drug-re ...... notypes with genetic mutations

@en

Predicting extensively drug-re ...... notypes with genetic mutations

@nl

prefLabel

Predicting extensively drug-re ...... notypes with genetic mutations

@ast

Predicting extensively drug-re ...... notypes with genetic mutations

@en

Predicting extensively drug-re ...... notypes with genetic mutations

@nl

P1433

Q28397752-EE9A265C-E106-446D-9966-1F9E99CCCA3A

P1476

Q28397752-C8EDD738-9C1B-4E01-AECA-E37C0FC86DB5

P2093

Q28397752-0A4D2E1E-C6D6-4C07-BA2D-B466C7CEDEF1

Q28397752-0D0B1272-F42D-4D89-B18E-B1A0677776D7

Q28397752-18C38705-A35D-4652-8ED7-6854B5CC91DC

Q28397752-21551CFF-5061-4928-825D-5DD2A3EE6BF9

Q28397752-25ACC525-4F37-4F21-BBF4-E745E2F2EA35

Q28397752-3FAE80BC-406D-4D63-8850-380402DEF2D8

Q28397752-41C358C2-6CE6-4A23-A345-F1137FC08F41

Q28397752-7AEB849E-DEA5-4F5D-BE04-65D4CA431963

Q28397752-935AB9E4-6D0A-4986-A7B2-9A63B2A60724

Q28397752-95DBCB01-9D48-40EB-9233-14F11AC424AE

P2860

Q28397752-104BBA4D-1581-433D-9286-7204735194EF

Q28397752-15FDB20F-BC18-4D25-91E9-0F75F565D5FC

Q28397752-196ADC0C-0EDA-42D7-BECA-F6E725AF7F4F

Q28397752-19F945FD-5609-4774-B55D-42B86A1E31EB

Q28397752-1C2B7CCE-2F0A-4193-8C95-09B60DA83DE5

Q28397752-22D60F69-9CA7-4DF0-B5CD-8F3BBF923F97

Q28397752-2A886A76-3BB2-4143-AE29-4459AF1594E0

Q28397752-2B79BD9E-0178-4FE9-942F-5581DF958D8C

Q28397752-31BBA1C5-E80C-4F90-9CC4-6A0217A58961

Q28397752-3C2D4F8C-9877-4AB4-8B6B-C791912738A4

P304

Q28397752-D4FE1D86-440B-4049-813F-06A4E202B744

P31

Q28397752-7331FCDE-A29E-4FBB-8DFC-4A260C3CF01D

P3181

Q28397752-5D7A250D-27CD-4465-8F81-C3757F52CB30

P356

Q28397752-45605D26-C3FD-4327-B110-DB1D17296A9A

P407

Q28397752-CFF58C37-EC5A-40C6-BE72-F3215947DA01

P433

Q28397752-D3E553EB-9B2D-49E1-B790-2C3D91F00613

P478

Q28397752-2DAF4105-F504-4B1C-AB90-5D7C829B7C68

P50

Q28397752-DE2688F8-896D-4B8F-AB34-DC8849DA5312

P577

Q28397752-B7018507-42E8-421C-B3CF-93940CB86F7B

P698

Q28397752-8DAE13E5-7C2D-4FE8-8A02-7609D8C5756B

P921

Q28397752-38B37DDE-C476-46E6-BC76-7024AFD7645F

P932

Q28397752-5061583B-C941-47BD-BA3C-1BC80DF2B6C4

P3181

P356

P1433

Journal of Clinical Microbiology

P1476

Predicting extensively drug-re ...... notypes with genetic mutations

@en

P2093

Antonino Catanzaro

http://www.w3.org/2001/XMLSchema#string

Ashu Chawla

http://www.w3.org/2001/XMLSchema#string

Camilla Rodrigues

http://www.w3.org/2001/XMLSchema#string

Donald Catanzaro

http://www.w3.org/2001/XMLSchema#string

Edward Desmond

http://www.w3.org/2001/XMLSchema#string

Faramarz Valafar

http://www.w3.org/2001/XMLSchema#string

Grace Lin

http://www.w3.org/2001/XMLSchema#string

James Douglas

http://www.w3.org/2001/XMLSchema#string

Jessica Torres

http://www.w3.org/2001/XMLSchema#string

Kathy Eisenach

http://www.w3.org/2001/XMLSchema#string

P2860

Natural infection of guinea pigs exposed to patients with highly drug-resistant tuberculosis

Two-sided confidence intervals for the single proportion: comparison of seven methods

The infectiousness of tuberculosis patients coinfected with HIV

Tuberculosis drug resistance mutation database

Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review

The impact and cost of scaling up GeneXpert MTB/RIF in South Africa

Molecular determinants of drug resistance in tuberculosis.

Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities

Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.

GeneXpert--a game-changer for tuberculosis control?

P304

781-789

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1373343

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/JCM.02701-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24353002

http://www.w3.org/2001/XMLSchema#string

P921

Mycobacterium tuberculosis

P932

3957771

http://www.w3.org/2001/XMLSchema#string